US health officials suspended the license for the IXCIQ vaccine against the Chikungunia virus following “severe adverse incidents” reports, saying on Monday by the drug French manufacturer.
Please follow and like us:
US suspends chikungunya vaccine Ixchiq over 'serious' side effects: Valneva
